Medscape - July 26, 2022
Robert Grossberg, M.D., comments on an analysis that found certain anti-viral treatments for COVID-19 may help patients avoid hospitalization or death, but notes that the studies were done only in unvaccinated participants and before the Omicron variant emerged. Dr. Grossberg is associate professor of medicine at Einstein and an infectious disease physician at Montefiore.
Dr. Grossberg's Profile
Medscape - July 25, 2022
Matthias Eikermann, M.D., discusses his study that found that patients who identified as Black versus those who identified as white have a higher risk of adverse discharge to a nursing home after surgery. Dr. Eikermann is professor and chair of anesthesiology at Einstein and Montefiore. chair of anesthesiology at Montefiore.
Dr. Eikermann's Profile
Medscape - July 20, 2022
Dawn Buse, Ph.D., leads a discussion on the effects of stigma against people who have chronic migraine and ways that physicians and patients can address stigmatizing attitudes through advocacy and education. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology at Einstein.
Dr. Buse's ProfileMore coverage on Dr. Buse
MedPageToday - July 8, 2022
Eric Hollander, M.D., discusses results of a large, randomized clinical trial that found the drug balovaptan did not improve socialization and communication among those with pediatric autism spectrum disorder (ASD). Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore and Einstein.
Additional coverage includes Medscape
Dr. Hollander's ProfileMore coverage on Dr. Hollander
The City - July 5, 2022
Antoinette Danvers, M.D., explains the importance of abortion training and Montefiore and Einstein's efforts to offer it to medical residents in states where abortion is now illegal. Dr. Danvers is associate professor of obstetrics & gynecology and women's health at Einstein and director of the division of complex family planning at Montefiore.
Dr. Danvers' Profile
MedPageToday - July 1, 2022
In a MedPage Today commentary, Einstein medical students Sarah McNeilly and Vivian Kim call for national organizations overseeing medical education to implement a universal curricular standard for abortion education.
Academic Minute - June 22, 2022
Steven Walkley, D.V.M., Ph.D., describes "gene teams" at Einstein and Montefiore in which physicians and scientists provide clinical information and research updates to parents of children diagnosed with rare genetic diseases. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology.
Dr. Walkley's ProfileMore coverage on Dr. Walkley
MedPageToday - June 19, 2022
Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
The Scientist - June 16, 2022
Meredith Hawkins, M.D., M.S., explains her study that describes a metabolically distinct type of diabetes characterized by low body weight and problems with insulin secretion—a crucial step toward developing effective treatments. Dr. Hawkins is the founding director of the Global Diabetes Institute, professor of medicine, and the Harold and Muriel Block Chair in Medicine at Einstein.
Additional coverage includes UPI and The Hindu
Dr. Hawkins' ProfileMore coverage on Dr. Hawkins
Medscape - June 1, 2022
Noa Schwartz, M.D., M.S., comments on the discovery of a rare mutation in a person with systemic lupus erythematosus and the possibility that it could lead to new treatments for a subset of patients with the disease. Dr. Schwartz is assistant professor of medicine at Einstein and director of the Montefiore-Einstein Institute for Lupus Care and Research.
Dr. Schwartz's Profile
CNN - May 31, 2022
Joe Verghese, M.B.B.S., M.S., comments on a study that found adults over age 65 had an increased risk of dementia if they had both a decrease in their walking speed and signs of cognitive function decline. Dr. Verghese is chief of the integrated divisions of cognitive and motor aging and of geriatrics at Einstein and Montefiore. He also is the Murray D. Gross Memorial Faculty Scholar in Gerontology, director of the Resnick Gerontology Center, and professor in the Saul R. Korey Department of Neurology and of medicine at Einstein.
Additional coverage includes MedPage Today, Medscape
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - May 31, 2022
Simon Rego, Psy.D., says looking forward to things improves our mood and can make us less irritable. Dr. Rego is associate professor of psychiatry and behavioral sciences, chief of psychology, and director of psychology training at Einstein and Montefiore.
Dr. Rego's ProfileMore coverage on Dr. Rego
WNYC - May 26, 2022
Seth Congdon, M.D., describes the common and often debilitating symptoms of long COVID and stresses the importance of following up with physicians and specialists to address them. Dr. Congdon is assistant professor of medicine at Einstein and medical co-director of the COVID-19 Recovery (CORE) Clinic at Montefiore.
Dr. Congdon's Profile
New York Social Diary - May 25, 2022
The Women's Division of Albert Einstein College of Medicine recently held its 67th Spirit of Achievement Luncheon, an annual fundraiser to support biomedical research. The event has raised more than $100 million since its inception.
Additional coverage includes WWD, Park Magazine NY, and Silver Disobedience
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski